Actual Test imaging (for presentation purposes only)
SAN DIEGO, Nov. 12, 2020 (Investorideas.com Newswire) GBT Technologies Inc. (OTCPINK: GTCH) ("GBT", or the "Company"), announced that GBT Tokenize ("GBT/Tokenize") started research in the Kirlian Electrophotography imaging technique potentially aimed for inclusion within its qTerm device. GBT/Tokenize's qTerm, is a human vitals device powered by AI and is aimed to measure human vitals with a touch of a finger.
GBT/Tokenize encourages public participation in its research. Scientists and researchers that are interested to participate in our research are welcome to send us their material for evaluation at firstname.lastname@example.org
The human body emits various radiations such as infrared, electromagnetic radiation, low level visible light and ultraviolet radiation. This human biofield carries unique information which can potentially be useful for diagnosing and predicting diseases. The various aspects of this biofield can be measured in order to identify organ and/or tissue dysfunctions and therefore potentially detect early stages of possible diseases. Early detection is essential to ensure proper treatment and care.
Kirlian Electrophotography technique is a photographic method to capture the phenomenon of electrical coronal discharges which can be used to produce a human's organ biofield. The technique is based on shooting a high voltage charge through an object that is connected to a photographic plate. The resulting image typically includes a colored aura around the object. When performed on a human organ the aura is its biofield. The research will be focusing on using Kirlian imaging techniques for early disease diagnostics. GBT/Tokenize's Machine Learning system is aimed to analyze the biofield data and possible detection of onset disease. Based on Kirlian images and patterns, GBT/Tokenize's AI seeks to observe, study, analyze and ultimately alert physicians about possible underlying illnesses or symptoms. If developed and commercialized, such a system can be efficient for remote telemedicine diagnostics and medical advice.
"We are excited to start new research for our qTerm device" stated Danny Rittman, GBT's CTO. "This research is about the analysis of Kirlian electrophotography data in order to detect an onset of possible illnesses. Kirlian imaging can produce a bio-energy of human's organs and can perform as a diagnostic tool. Using Kirlian imaging, we believe it is possible to produce a measure of human energy levels and examine changes in the energy distribution throughout the organ(s). We are attempting to determine if we can implement Kirlian imaging for qTerm by means of producing a human's finger aura (i.e. its biofield). Along with qTerm vitals measurement, the goal is to potentially provide a Kirilian image. In turn, using our Machine learning technology, we are seeking to develop an analysis of the biofield and, in turn, provide a diagnostic and potential medical issues classification. We believe this type of system, if fully developed and commercialized, could be very efficient as additional diagnostic system. We commenced our research and we encourage public participation in this research and we will share our findings on our website qterm.me" continued Dr. Rittman.
Illustration of Kirlian photograph of a fingertip, 1989:
Actual Test imaging (for presentation purposes only):
About GBT Technologies Inc.
GBT Technologies Inc. (OTC PINK: GTCH) ("GBT") (http://gbtti.com) is a development-stage company which considers itself a native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology platforms. GBT has a portfolio of Intellectual Property that, if commercialized, is designed to include smart microchips, mobile and security applications and protocols and supporting cloud software. GBT's system envisions the creation of a global mesh network. The core of the system will be its advanced microchip technology that can be installed in any mobile or fixed device worldwide. GBT envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.
Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
Dr. Danny Rittman, CTO
GBT Technologies Inc.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp
Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Like Tech Stocks? View our Tech Stocks Directory